Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
14.04
-0.17 (-1.20%)
At close: Apr 28, 2026, 4:00 PM EDT
14.32
+0.28 (1.99%)
After-hours: Apr 28, 2026, 7:30 PM EDT
Adaptive Biotechnologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Revenue | 276.98 | 178.96 | 170.28 | 185.31 | 154.34 | Upgrade
|
| Revenue Growth (YoY) | 54.77% | 5.10% | -8.11% | 20.06% | 56.88% | Upgrade
|
| Cost of Revenue | 71.36 | 72.08 | 75.55 | 199.67 | 191.64 | Upgrade
|
| Gross Profit | 205.62 | 106.88 | 94.72 | -14.36 | -37.3 | Upgrade
|
| Selling, General & Admin | 167.27 | 157.57 | 172.51 | 184.13 | 169.97 | Upgrade
|
| Research & Development | 93.77 | 102.95 | 122.12 | - | - | Upgrade
|
| Amortization of Goodwill & Intangibles | 1.7 | 1.7 | 1.7 | 1.7 | 1.7 | Upgrade
|
| Operating Expenses | 262.74 | 262.22 | 296.33 | 185.83 | 171.67 | Upgrade
|
| Operating Income | -57.12 | -155.34 | -201.61 | -200.19 | -208.97 | Upgrade
|
| Interest Expense | -11.78 | -11.58 | -13.8 | -4.24 | - | Upgrade
|
| Interest & Investment Income | - | - | - | 4.8 | 8.9 | Upgrade
|
| Other Non Operating Income (Expenses) | 6.93 | 6.33 | 6.35 | - | - | Upgrade
|
| EBT Excluding Unusual Items | -61.97 | -160.6 | -209.06 | -199.63 | -200.07 | Upgrade
|
| Merger & Restructuring Charges | - | -7.21 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 2.51 | 8.21 | 9.18 | -0.74 | -7.23 | Upgrade
|
| Asset Writedown | - | - | -25.43 | - | - | Upgrade
|
| Pretax Income | -59.46 | -159.6 | -225.3 | -200.37 | -207.3 | Upgrade
|
| Earnings From Continuing Operations | -59.46 | -159.6 | -225.3 | -200.37 | -207.3 | Upgrade
|
| Minority Interest in Earnings | -0.04 | 0.1 | 0.05 | 0.18 | 0.02 | Upgrade
|
| Net Income | -59.5 | -159.49 | -225.25 | -200.19 | -207.28 | Upgrade
|
| Net Income to Common | -59.5 | -159.49 | -225.25 | -200.19 | -207.28 | Upgrade
|
| Shares Outstanding (Basic) | 152 | 147 | 144 | 143 | 140 | Upgrade
|
| Shares Outstanding (Diluted) | 152 | 147 | 144 | 143 | 140 | Upgrade
|
| Shares Change (YoY) | 3.14% | 1.88% | 1.31% | 1.54% | 6.96% | Upgrade
|
| EPS (Basic) | -0.39 | -1.08 | -1.56 | -1.40 | -1.48 | Upgrade
|
| EPS (Diluted) | -0.39 | -1.08 | -1.56 | -1.40 | -1.48 | Upgrade
|
| Free Cash Flow | -48.95 | -98.88 | -167.02 | -200.29 | -254.47 | Upgrade
|
| Free Cash Flow Per Share | -0.32 | -0.67 | -1.16 | -1.41 | -1.81 | Upgrade
|
| Gross Margin | 74.24% | 59.72% | 55.63% | -7.75% | -24.17% | Upgrade
|
| Operating Margin | -20.62% | -86.80% | -118.40% | -108.03% | -135.39% | Upgrade
|
| Profit Margin | -21.48% | -89.12% | -132.28% | -108.03% | -134.30% | Upgrade
|
| Free Cash Flow Margin | -17.67% | -55.25% | -98.09% | -108.09% | -164.87% | Upgrade
|
| EBITDA | -39.29 | -136.09 | -179.38 | -179.27 | -195.01 | Upgrade
|
| EBITDA Margin | -14.19% | -76.05% | -105.34% | -96.74% | -126.35% | Upgrade
|
| D&A For EBITDA | 17.83 | 19.26 | 22.23 | 20.92 | 13.95 | Upgrade
|
| EBIT | -57.12 | -155.34 | -201.61 | -200.19 | -208.97 | Upgrade
|
| EBIT Margin | -20.62% | -86.80% | -118.40% | -108.03% | -135.39% | Upgrade
|
| Advertising Expenses | 4.1 | 6.1 | 8.6 | 13.7 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.